Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD
1 other identifier
interventional
200
1 country
1
Brief Summary
Invasive ventilation(IV) remains one key cornerstone to reduce neonatal mortality for preterm infants with respiratory distress syndrome(RDS) and/or acute respiratory distress syndrome(ARDS). However, it is also related to increased risks of ventilator-associated lung injury and escalation of pulmonary inflammation, and which finally result in bronchopulmonary dysplasia (BPD). Early weaning from IV in newborn infants with BPD is therefore a key procedure to reduce these risks above.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2021
CompletedStudy Start
First participant enrolled
May 20, 2021
CompletedFirst Posted
Study publicly available on registry
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 14, 2022
October 1, 2022
3.6 years
February 26, 2021
October 13, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
re-intubation rate
the newborn infants with ventilated BPD is reintubated after extubation
seven days after extubation
death
the newborn infants with BPD die
seven days after extubation
the level of carbon dioxide
the level of carbon dioxide is measure after extubation between groups
seven days after extubation
Secondary Outcomes (2)
necrotizing entercolitis(NEC)
seven days after extubation
intraventricular hemorrhage(IVH)
seven days after extubation
Study Arms (2)
NHFOV
EXPERIMENTALAfter documenting parental consent, the ventilated infants with BPD were randomly assigned to NHFOV
NCPAP
ACTIVE COMPARATORAfter documenting parental consent, the ventilated infants with BPD were randomly assigned to NCPAP
Interventions
Eligibility Criteria
You may qualify if:
- Eligibility requirements for neonates:
- The gestational age is less than 32 weeks
- The preterm neonates are diagnosed with BPD and need invasive ventilation
- Extubation and subsequent noninvasive ventilation is ready to be carried out
You may not qualify if:
- one of the following conditions is needed:
- there were no intraventricular hemorrhage(IVH) grades 3 or 4
- major congenital anomalies
- parents' decision not to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chen(陈)
Chongqing, Chongqing Municipality, 400014, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- After documenting parental consent, these ventilated infants with BPD were randomly assigned to either NHFOV or NCPAP using a table of random numbers and sealed opaque envelopes when they were eligible for extubation. Blinding to doctor was not possible due to the nature of the intervention, is not necessary to participant.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- director
Study Record Dates
First Submitted
February 26, 2021
First Posted
May 28, 2021
Study Start
May 20, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
October 14, 2022
Record last verified: 2022-10